Extreme ranges of GABA launched by astrocytes impair the mind’s potential to extinguish concern responses in PTSD, however a newly recognized drug goal affords promising hope for remedy.
Many individuals with post-traumatic stress dysfunction (PTSD) proceed to relive painful recollections lengthy after the precise risk is gone. Their brains appear unable to let go of concern, a phenomenon that has lengthy puzzled scientists and made efficient remedy tough. Present drugs that concentrate on serotonin receptors typically present solely restricted aid, and normally assist only a fraction of these affected.
Now, researchers from the Institute for Fundamental Science (IBS) and Ewha Womans College have recognized a beforehand unknown mind course of that could be accountable for this persistent concern response. They’ve additionally discovered a possible remedy that might change how PTSD is managed.
The examine, led by Dr. C. Justin LEE from the IBS Middle for Cognition and Sociality and Professor LYOO In Kyoon from Ewha Womans College, found that astrocytes (star-shaped assist cells within the mind) can produce an excessive amount of GABA (gamma-aminobutyric acid). This extra GABA interferes with the mind’s potential to suppress fear-related recollections, a key problem for folks with PTSD.
Importantly, the crew examined a drug referred to as KDS2010 that crosses the blood-brain barrier and particularly blocks the monoamine oxidase B enzyme, which drives this irregular GABA manufacturing. In mouse fashions, the drug was capable of cut back PTSD-like signs. KDS2010 has already accomplished Section 1 human security trials, positioning it as a promising choice for future PTSD remedy.
Excessive GABA Ranges and Lowered Mind Exercise
PTSD stays tough to deal with, with present drugs focusing on serotonin pathways offering restricted aid for a lot of sufferers. The brand new examine targeted on the medial prefrontal cortex (mPFC), a area of the mind essential for regulating concern, and located that PTSD sufferers had unusually excessive ranges of GABA and lowered cerebral blood move on this space. These findings emerged from mind imaging research of greater than 380 members. Importantly, GABA ranges decreased in sufferers who confirmed medical enchancment, pointing to the chemical’s central function in restoration.
To uncover the origin of this extra GABA, the researchers examined postmortem human mind tissue and used PTSD-like mouse fashions. They found that astrocytes, not neurons, have been producing irregular quantities of GABA by way of the enzyme monoamine oxidase B (MAOB). This astrocyte-derived GABA impaired neural exercise, blocking the mind’s potential to neglect traumatic recollections.
When the researchers administered KDS2010, a extremely selective, reversible MAOB inhibitor developed at IBS, the mice confirmed normalized mind exercise and have been capable of extinguish concern responses. The drug lowered GABA ranges, restored blood move within the mPFC, and re-enabled reminiscence extinction mechanisms. The examine thus confirms astrocytic MAOB as a central driver of PTSD signs, and MAOB inhibition as a viable therapeutic path.
A Reverse Translational Method
A significant problem of the examine was linking medical findings in people with mobile mechanisms within the lab. The researchers addressed this by making use of a “reverse translational” technique: they started with medical mind scans and moved backward to determine the mobile supply of dysfunction, then confirmed the mechanism and examined drug results in animal fashions. This method led to a brand new understanding of how glial cells — lengthy regarded as passive — actively form psychiatric signs.
“This examine is the primary to determine astrocyte-derived GABA as a key pathological driver of concern extinction deficit in PTSD,” mentioned Dr. WON Woojin, a postdoctoral researcher and co-first writer of the examine. “Our findings not solely uncover a novel astrocyte-based mechanism underlying PTSD, but in addition present preclinical proof for a brand new therapeutic method utilizing an MAOB inhibitor.”
Director C. Justin LEE, who led the examine, emphasised that “This work represents a profitable instance of reverse translational analysis, the place medical findings in human guided the invention of underlying mechanisms in animal fashions. By figuring out astrocytic GABA as a pathological driver in PTSD and focusing on it by way of MAOB inhibition, the examine opens a very new therapeutic paradigm not just for PTSD but in addition for different neuropsychiatric problems akin to panic dysfunction, despair, and schizophrenia.”
The researchers plan to additional examine astrocyte-targeted therapies for numerous neuropsychiatric problems. With KDS2010 presently present process Section 2 medical trials, this discovery could quickly result in new choices for sufferers whose signs haven’t responded to traditional therapies.
Reference: “Astrocytic gamma-aminobutyric acid dysregulation as a therapeutic goal for posttraumatic stress dysfunction” by Sujung Yoon, Woojin Gained, Suji Lee, Kayoung Han, Eunji Ha, Juheon Lee, Seung Jae Hyeon, Yoonji Joo, Haejin Hong, Hyangwon Lee, Yumi Track, Ki Duk Park, Bertrand R. Huber, Junghee Lee, Richard A. E. Edden, Minah Suh, Hoon Ryu, C. Justin Lee and In Kyoon Lyoo, 28 July 2025, Sign Transduction and Focused Remedy.
DOI: 10.1038/s41392-025-02317-5
Funding: Institute for Fundamental Science
